Stability studies of the product batches showed an out-of-specification result for active substance content, which may lead to incorrect dosing of the medicine. Potential effects: lack of treatment efficacy or overdose, complications, risk to health.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product from batches 9F119A and 9F119B; if you have it, return the medicine to a pharmacy or consult a doctor or pharmacist.
The Chief Pharmaceutical Inspector withdrew batches 9F119A and 9F119B of Oxydolor 40 mg prolonged-release tablets from the market nationwide and granted the decision immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related